Arecor appoints Sarah Howell COO
This article was originally published in Scrip
Executive Summary
Arecor, a company advancing aqueous formulation solutions for proteins, peptides and vaccines, has appointed Dr Sarah Howell chief operating officer. Dr Howell was most recently vice-president for CMC and technical development at BTG, and previously held senior roles in product development and manufacturing for UCB-Celltech and GlaxoSmithKline. She is an active member of the BioIndustry Association manufacturing advisory committee.